Accelerated chronic skin changes without allograft vasculopathy: A 10-year outcome report after face transplantation.

[1]  B. Pomahac,et al.  Recognizing Emotional Expression as an Outcome Measure After Face Transplant , 2020, JAMA network open.

[2]  B. Devauchelle,et al.  Role of flow magnetic resonance imaging in the monitoring of facial allotransplantations: preliminary results on graft vasculopathy. , 2020, International journal of oral and maxillofacial surgery.

[3]  J. Plock,et al.  The Significance of Vascular Alterations in Acute and Chronic Rejection for Vascularized Composite Allotransplantation , 2019, Journal of Vascular Research.

[4]  B. Pomahac,et al.  Five-Year Follow-up after Face Transplantation. , 2019, The New England journal of medicine.

[5]  J. Pawlotsky.  Retreatment of Hepatitis C Virus-Infected Patients with Direct-Acting Antiviral Failures , 2019, Seminars in Liver Disease.

[6]  B. Pomahac,et al.  Novel immunological and clinical insights in vascularized composite allotransplantation , 2019, Current opinion in organ transplantation.

[7]  C. Lian,et al.  Chronic rejection of human face allografts , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  Jean Kanitakis,et al.  Chronic rejection in vascularized composite allotransplantation , 2018, Current opinion in organ transplantation.

[9]  C. Bonorino,et al.  March1-dependent modulation of donor MHC II on CD103+ dendritic cells mitigates alloimmunity , 2018, Nature Communications.

[10]  Min-jung Park,et al.  IL-1-IL-17 Signaling Axis Contributes to Fibrosis and Inflammation in Two Different Murine Models of Systemic Sclerosis , 2018, Front. Immunol..

[11]  S. Testelin,et al.  Face Transplantation: Partial Graft Loss of the First Case 10 Years Later , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  K. V. van Lierde,et al.  Facial nerve regeneration after facial allotransplantation: A longitudinal clinical and electromyographic follow-up of lip movements during speech. , 2017, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[13]  M. Manns,et al.  Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection , 2017, The New England journal of medicine.

[14]  F. Bellivier,et al.  Face transplant: long-term follow-up and results of a prospective open study , 2016, The Lancet.

[15]  Allyson L. Byrd,et al.  Temporal Stability of the Human Skin Microbiome , 2016, Cell.

[16]  C. Lian,et al.  Codominant Role of Interferon‐γ– and Interleukin‐17–Producing T Cells During Rejection in Full Facial Transplant Recipients , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  M. Selim,et al.  Vascularized composite allotransplantation: a closer look at the banff working classification , 2016, Transplant international : official journal of the European Society for Organ Transplantation.

[18]  T. Asselah,et al.  Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection. , 2015, The New England journal of medicine.

[19]  S. Testelin,et al.  Clinicopathological Findings of Chronic Rejection in a Face Grafted Patient , 2015, Transplantation.

[20]  C. Lian,et al.  Utility of Sentinel Flaps in Assessing Facial Allograft Rejection , 2015, Plastic and reconstructive surgery.

[21]  B. Pomahac,et al.  Functional Outcomes of Face Transplantation , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  C. Lian,et al.  Biomarker evaluation of face transplant rejection: association of donor T cells with target cell injury , 2014, Modern Pathology.

[23]  B. Pomahac,et al.  Facial allotransplantation: a 3-year follow-up report. , 2013, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[24]  M. Fujimoto,et al.  Impaired IL-17 Signaling Pathway Contributes to the Increased Collagen Expression in Scleroderma Fibroblasts , 2012, The Journal of Immunology.

[25]  A. Israni,et al.  Spectrum of cancer risk among US solid organ transplant recipients. , 2011, JAMA.

[26]  S. Chimenti,et al.  Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. , 2011, The Journal of investigative dermatology.

[27]  B. Pomahac,et al.  Restoration of Facial Form and Function After Severe Disfigurement from Burn Injury by a Composite Facial Allograft , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[28]  E. Engels,et al.  Incidence and Risk Factors for Hepatocellular Carcinoma After Solid Organ Transplantation , 2008, Transplantation.

[29]  A. Kirk,et al.  The Banff 2007 Working Classification of Skin‐Containing Composite Tissue Allograft Pathology , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.